Overexpression of Ets‐1 proto‐oncogene in latent and clinical prostatic carcinomas
- 5 February 2005
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 46 (2), 202-208
- https://doi.org/10.1111/j.1365-2559.2005.02059.x
Abstract
Aims : The high incidence of clinically diagnosed prostatic cancer is exceeded by the frequency of tumours detected at autopsy. The Ets‐1 proto‐oncogene is expressed by a variety of malignant and normal tissues. Therefore, in this study, expression of Ets‐1 protein was investigated in ‘latent’ prostatic cancer detected at autopsy, compared with benign prostatic hyperplasia, normal prostatic tissues and clinical prostatic cancer. Methods and results : Using immunohistochemistry, we analysed Ets‐1 expression in 95 prostatic specimens including 19 cases of latent prostatic carcinoma (LPC) and 55 cases of clinical prostatic carcinoma (CPC), 11 cases of benign prostatic hyperplasia (BPH) and 10 cases of normal prostate (NP). Differences in the incidence of LPC and CPC suggest different courses for the biological progression of prostatic cancer. There was a significant difference in the degree of Ets‐1 expression in CPC and LPC (P < 0.05). Ets‐1 was not expressed in BPH and NP, but in malignant cases (57 of 74; 77.0%) commonly demonstrated immunoreactivity in the tumour cells. In our study the expression of Ets‐1 between benign and malignant, and well, moderately and poorly differentiated adenocarcinomas of prostatic cancer showed significant differences. The presence of Ets‐1 mRNA was confirmed by in‐situ hybridization in human prostatic tissues. Conclusion : Our results suggest that Ets‐1 might play an important role in carcinogenesis and/or the progression of human prostatic carcinomas.Keywords
This publication has 30 references indexed in Scilit:
- Expression of the ets-1 Proto-Oncogene in Human Colorectal CarcinomaLaboratory Investigation, 2001
- Ets transcription factors: nuclear effectors of the Ras–MAP-kinase signaling pathwayTrends in Biochemical Sciences, 1998
- Invasive tumors induce c‐ets1 transcription factor expression in adjacent stromaBiology of the Cell, 1995
- p53 Mutations Occur in Clinical, but Not Latent, Human Prostate CarcinomaJapanese Journal of Cancer Research, 1995
- The Ets family of transcription factorsJBIC Journal of Biological Inorganic Chemistry, 1993
- Oncogenic conversion of transcription factors by chromosomal translocationsCell, 1991
- Oncogenic potential of bcl-2 demonstrated by gene transferNature, 1988
- Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesisDevelopmental Biology, 1988
- PATTERNS OF PROGRESSION IN PROSTATE CANCERThe Lancet, 1986
- Tripartite structure of the avian erythroblastosis virus E26 transforming geneNature, 1983